Extensive work in cancer immunotherapy has shown that the CCL21/CCR7 expression axis promotes growth and metastasis in a variety of tumor types, including melanoma, breast, thyroid, colon, head, and neck cancers (54–59). Here, CCR7 is linked to melanoma.